Your clinician should explain both the benefits of GLP-1 therapyincluding improved glycaemic control, weight loss, and cardiovascular protectionand the theoretical risks based on animal data
It does not mean it must be prescribed, and it does not mean it cannot be prescribed for other reasons
10.1007/s11104-017-3207-z Plant Soil 87 ZhangY.LiuJ.ZhouY.GongT.WangJ.GeY
Hypoglycemia risk increases when tirzepatide is used in combination with insulin or sulfonylureas, necessitating dose adjustments of these concomitant medications
Because of the paucity of confirmatory studies, the use of epithalon in human subjects for any indication must be for research purposes only
Semaglutide, commonly used for managing type 2 diabetes and obesity, has proven benefits